- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- Alabama Oncology, Shelby Alabaster, Alabama, United States
- Alabama Oncology, Bessemer Bessemer, Alabama, United States
- Alabama Oncology, St Vincent's Birmingham Birmingham, Alabama, United States
- Alabama Oncology, Brookwood Birmingham, Alabama, United States
Clinical trial condition
Non-small Cell Lung Carcinoma
Explore clinical trials studying Non-small Cell Lung Carcinoma. Study availability and eligibility vary by location and protocol.
43 public trials
5 recruiting studies
Non-small Cell Lung Carcinoma trial results
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
Recruiting
Whole Body HER3 Quantification With Radiolabelled Patritumab Deruxtecan (HER3-DXd) PET/CT
NCT06222489
- Conditions
- Advanced Non-Small Cell Squamous Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
- Locations
-
- Antoni van Leeuwenhoek Amsterdam, North Holland, Netherlands
NCT04585750
- Conditions
- Adnexal Diseases, Advanced Malignant Neoplasm, Advanced Solid Tumor, +81 more
- Locations
-
- University of California Irvine Chao Family Comprehensive Cancer Center Irvine, California, United States
- University of San Diego Moores Cancer Center La Jolla, California, United States
- UCLA Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- USC Norris Comprehensive Cancer Center Los Angeles, California, United States
NCT07284186
- Conditions
- Adenocarcinoma, Adenocarcinoma Of Esophagus, Advanced Solid Tumor, +35 more
- Locations
-
- Research Site Scottsdale, Arizona, United States
- Research Site Duarte, California, United States
- Research Site Orange, California, United States
- Research Site Boston, Massachusetts, United States
NCT05393466
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
Not specified
Enrolling by invitation
Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection
NCT04762459
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Chinese Academy of Medical Science Beijing, Beijing Municipality, China
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
- Peking Union Medical College Hospital Beijing, China
- Hunan Cancer Hospital Changsha, China
Active, not recruiting
Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
NCT05358249
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +25 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- NYU School of Medicine New York, United States
- Novartis Investigative Site Leuven, Belgium
Active, not recruiting
Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment
NCT03731585
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Vaccine Therapy and Pembrolizumab in Treating Patients With Solid Tumors That Have Failed Prior Therapy
NCT02432963
- Conditions
- Adenocarcinoma, Adult Solid Neoplasm, Bladder Carcinoma, +74 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States